HYPOTHALAMIC DIGOXIN-MEDIATED MODEL FOR PARKINSON'S DISEASE
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis Ltd in International Journal of Neuroscience
- Vol. 113 (4), 515-536
- https://doi.org/10.1080/00207450390162263
Abstract
The isoprenoid pathway produces four key metabolites important in cellular function--digoxin (endogenous membrane Na+-K+ ATPase inhibitor), dolichol (important in N-glycosylation of proteins), ubiquinone (free-radical scavenger), and cholesterol (component of cellular membranes). This study assessed the changes in the isoprenoid pathway and the consequences of its dysfunction in Parkinson's disease (PD). There was an elevation in plasma HMG CoA reductase activity, serum digoxin and dolichol levels, and a reduction in serum magnesium, RBC membrane Na+-K+ ATPase activity, and serum ubiquinone levels. Serum tryptophan, serotonin, strychnine, nicotine, and quinolinic acid were elevated, while tyrosine, morphine, dopamine, and noradrenaline were decreased. The total serum glycosaminoglycans (GAG) and glycosaminoglycan fractions (except chondroitin sulphates and hyaluronic acid), the activity of GAG degrading enzymes, carbohydrate residues of serum glycoproteins, the activity of glycohydrolase-beta galactosidase, and serum glycolipids were elevated. HDL cholesterol was reduced and free fatty acids increased. The RBC membrane glycosaminoglycans, hexose and fucose residues of glycoproteins and cholesterol were reduced, while phospholipid was increased. The activity of all serum free-radical scavenging enzymes, concentration of glutathione, alpha tocopherol, iron binding capacity, and ceruloplasmin decreased significantly in PD, while the concentration of serum lipid peroxidation products and nitric oxide increased. A dysfunctional isoprenoid pathway and related cascade are important in the pathogenesis of Parkinson's disease. A hypothalamic digoxin mediated model for Parkinson's disease is also postulated.This publication has 28 references indexed in Scilit:
- Experimental Therapeutics of Neurodegenerative Disorders: Unmet NeedsScience, 1998
- Genetic Classification of Primary Neurodegenerative DiseaseScience, 1998
- Tangle disentanglementNature, 1996
- Keeping synapses up to speedNature, 1995
- Plasma lipids and cholesterol esterification in Alzheimer's diseaseMechanisms of Ageing and Development, 1994
- Ubiquinone, dolichol, and cholesterol metabolism in aging and Alzheimer's diseaseBiochemistry and Cell Biology, 1992
- Effects of Dietary Magnesium Supplementation on Diurnal Variations of Blood Pressure and Plasma Na+, K+-ATPase Activity in Essential Hypertension.Japanese Heart Journal, 1992
- T-cell development and transmembrane signaling: changing biological responses through an unchanging receptorImmunology Today, 1991
- Regulation of the mevalonate pathwayNature, 1990
- Effect of magnesium deficiency on the metabolism of glycosamino-glycans in ratsJournal of Biosciences, 1986